Back to Search
Start Over
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report.
- Source :
-
Journal of neurology [J Neurol] 2024 Jul; Vol. 271 (7), pp. 4655-4659. Date of Electronic Publication: 2024 Apr 11. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1432-1459
- Volume :
- 271
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Journal of neurology
- Publication Type :
- Report
- Accession number :
- 38602546
- Full Text :
- https://doi.org/10.1007/s00415-024-12367-4